2. The market for EpiPensConsider the pharmaceutical company Mylan that produces epinephrine injection devices called EpiPens. In the presence of other firms producing substitutes for this good, the price of EpiPens is $150.
Now suppose that competitors to Mylan no longer produce epinephrine injection devices, so Mylan now has pricing power in this market. As the economist on staff at Mylan, you are charged with the task of figuring out what your company’s new pricing strategy should be.
The following graph shows the marginal cost (MC), which is assumed to be constant, and the average total cost (ATC) of Mylan. The graph also shows the demand curve (D) for EpiPens and the marginal revenue curve (MR) once the firm has market power.
On the graph, use the grey point (star symbol) to indicate the quantity of EpiPens demanded if Mylan continues to charge $150. Dashed drop lines will automatically extend to both axes.
QDat $150Profit MaxATC at Profit MaxProfit01234567891010009008007006005004003002001000PRICE (Dollars per EpiPen)QUANTITY (Thousands of EpiPens)MRDMCATC
If Mylan continues to charge $150 per EpiPen, Mylan will earn economic profit.
True or False: Given the demand curve for EpiPens, you should tell Mylan’s CEO that total revenue will decrease if she raises the price of EpiPens because the demand curve in this region is relatively inelastic.
TrueFalse
Leave a Reply